Guillermo Herrera, President and Chief Executive Officer of NeoPharm, Inc.,
Rings The NASDAQ Stock Market Closing Bell

Monday, July 17, 2006
at NASDAQ's MarketSite
in New York City.

NeoPharm, Inc.
[NEOL]

Guillermo Herrera, President & Chief Executive Officer of NeoPharm, Inc. (NEOL) presides over the closing bell.

NeoPharm employees share a common goal: bringing hope to cancer patients and their families through the research and development of new cancer drugs and therapies. The Company's oncology portfolio is built on two novel, proprietary platforms: a tumor-targeting platform, and the NeoLipid(r) Liposomal Drug Delivery platform. Through its research and clinical studies, as well as its work with physicians, scientists, and advocacy groups, NeoPharm is helping to enhance the lives of cancer patients.
About NeoPharm, Inc. (NEOL):
NeoPharm, Inc., based in Waukegan, Illinois, is a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative cancer drugs for therapeutic applications. Additional information, including ongoing clinical trials, can be obtained by visiting NeoPharm's Web site at www.neopharm.com.

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 7/17/2006 Download Hi-Res Quality Photo of this NASDAQ Market Open - Pictured: Guillermo Herrera, President and Chief Executive Officer of NeoPharm, Inc., rings the Closing Bell These photos are Copyright 2006, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2006, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.